MP02-18 EFFICACY AND SAFETY OF DA8010, A NOVEL M3 ANTAGONIST, IN PATIENTS WITH OVERACTIVE BLADDER: RANDOMIZED, DOUBLE-BLIND, PHASE 2 STUDY
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details